CHERIE NYDEGGER: Open Payments
NPI 1891448593 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 18 payments from 12 companies in 2025. Trend: 2023 $5,687 · 2024 $67 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| Vifor Pharma, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: TARPEYO, PURIFIED CORTROPHIN GEL, Ozempic, Fabhalta, Veltassa, TAVNEOS, BENLYSTA, ACTHAR.
Industry payments across MO — which companies pay providers there.
